Literature DB >> 17089174

Predictors of long-term survival in node-positive gastric carcinoma patients with curative resection.

Dong Yi Kim1, Jae Kyoon Joo, Young Kyu Park, Seong Yeob Ryu, Young Jin Kim, Shin Kon Kim.   

Abstract

BACKGROUND AND AIMS: We analyzed the clinicopathologic features of node-positive gastric carcinoma patients who were long-term survivors (5 years or longer) and evaluated the predictive factors associated with long-term survival. PATIENTS AND METHODS: Of 554 node-positive gastric carcinoma patients with curative resection, 161 (29.1%) were long-term survivors, and 393 died of the disease before 5 years.
RESULTS: The long-term survivor group had a recurrence rate of 16.1%, while the recurrence rate was 95.4% in the short-term survivor group (P < 0.05). The mean tumor size in the long-term survivors (4.5 cm) was significantly smaller than that in the short-term survivors (5.3 cm; P < 0.001). A depth of invasion greater than T3 was found more frequently in the short-term survivor group (88.1%) than in the long-term survivor group (70.1%; P < 0.001). Using Cox's proportional hazard regression model, the only factor found to be an independent, statistically significant prognostic parameter was tumor size (risk ratio, 0.301; 95% confidence interval, 0.10-0.88; P < 0.05).
CONCLUSION: The tumor size emerged as the only independent, significant factor for the prediction of long-term survival in node-positive gastric carcinoma patients with curative resection.

Entities:  

Mesh:

Year:  2006        PMID: 17089174     DOI: 10.1007/s00423-006-0114-9

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  19 in total

1.  Prediction of survival time after curative surgery for advanced gastric cancer.

Authors:  S Moriguchi; Y Maehara; D Korenaga; K Sugimachi; Y Hayashi; Y Nose
Journal:  Eur J Surg Oncol       Date:  1992-06       Impact factor: 4.424

Review 2.  Clinicopathologic studies of gastric carcinoma.

Authors:  M Mori; K Sugimachi
Journal:  Semin Surg Oncol       Date:  1990

Review 3.  Epidemiology of gastric cancer.

Authors:  A I Neugut; M Hayek; G Howe
Journal:  Semin Oncol       Date:  1996-06       Impact factor: 4.929

4.  Predictors of long-term survival in pN3 gastric cancer patients.

Authors:  Junuk Kim; Jae Ho Cheong; Woo Jin Hyung; Jianguo Shen; Seung Ho Choi; Sung Hoon Noh
Journal:  J Surg Oncol       Date:  2004-10-01       Impact factor: 3.454

5.  A clinicopathological study of gastric cancer with special reference to age of the patients: an analysis of 1,630 cases.

Authors:  T Mitsudomi; T Matsusaka; K Wakasugi; M Takenaka; K Kume; Y Fujinaga; H Teraoka; A Iwashita
Journal:  World J Surg       Date:  1989 Mar-Apr       Impact factor: 3.352

6.  Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy.

Authors:  K Nakamura; T Ueyama; T Yao; Z X Xuan; K Ambe; Y Adachi; Y Yakeishi; A Matsukuma; M Enjoji
Journal:  Cancer       Date:  1992-09-01       Impact factor: 6.860

7.  Clinicopathological analysis of the intestinal type and diffuse type of gastric carcinoma.

Authors:  S Noda; K Soejima; K Inokuchi
Journal:  Jpn J Surg       Date:  1980-12

8.  Should patients over 80 years old be operated on for colorectal or gastric cancer?

Authors:  S Houry; J Amenabar; A Rezvani; M Huguier
Journal:  Hepatogastroenterology       Date:  1994-12

9.  Death due to recurrence following curative resection of early gastric cancer depends on age of the patient.

Authors:  S Moriguchi; T Odaka; Y Hayashi; Y Nose; Y Maehara; D Korenaga; K Sugimachi
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

10.  Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer.

Authors:  L E Harrison; M S Karpeh; M F Brennan
Journal:  J Gastrointest Surg       Date:  1998 Mar-Apr       Impact factor: 3.267

View more
  9 in total

1.  Clinicopathologic characteristics of serosa-positive gastric carcinoma in elderly patients.

Authors:  Ho Gun Kim; Hyo Kang; Dong Yi Kim; Jae Kyoon Joo; Seong Yeob Ryu; Jae Hyuk Lee
Journal:  J Korean Surg Soc       Date:  2011-07-11

2.  Expression levels of microRNA-192 and -215 in gastric carcinoma.

Authors:  Yeunpo Chiang; Xin Zhou; Zhenning Wang; Yongxi Song; Zhuangkai Liu; Fang Zhao; Jinliang Zhu; Huimian Xu
Journal:  Pathol Oncol Res       Date:  2011-12-29       Impact factor: 3.201

3.  Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance.

Authors:  Yue Chen; Yongxi Song; Zhenning Wang; Zhenyu Yue; Huimian Xu; Chengzhong Xing; Zhuangkai Liu
Journal:  J Gastrointest Surg       Date:  2010-04-27       Impact factor: 3.452

4.  Gastric cancer: Where is the place for the surgeon, the oncologist and the endoscopist today?

Authors:  Markus Menges
Journal:  World J Gastrointest Oncol       Date:  2011-01-15

5.  Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis.

Authors:  Lei Ge; Hai-Jiang Wang; Dong Yin; Cheng Lei; Jin-Feng Zhu; Xiao-Hui Cai; Guo-Qing Zhang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

6.  Safety and Feasibility of Carboplatin and Paclitaxel followed by Fluoropyrimidine Analogs and Radiation as Adjuvant Therapy for Gastric Cancer.

Authors:  Mohammad Mobayed; Lance K Heilbrun; Anthony F Shields; Tara Washington; Raghu Venkatramanamoorthy; Philip A Philip; Bassel F El-Rayes
Journal:  Case Rep Oncol       Date:  2009-11-21

Review 7.  Current strategies in systemic treatment of gastric cancer and cancer of the gastroesophageal junction.

Authors:  Markus Menges; Thomas Hoehler
Journal:  J Cancer Res Clin Oncol       Date:  2008-06-04       Impact factor: 4.553

Review 8.  Neoadjuvant Therapy of Gastric Cancer: A Decisive Step Forward.

Authors:  Markus Menges; Thomas Hoehler
Journal:  Gastrointest Tumors       Date:  2014-05-09

9.  Stage-stratified analysis of prognostic significance of tumor size in patients with gastric cancer.

Authors:  Hongliang Zu; Feng Wang; Yan Ma; Yingwei Xue
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.